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The introduction of the technique of intracytoplasmic sperm injection to achieve fertilization, especially using
surgically retrieved testicular or epididymal sperm from men with obstructive or non-obstructive azoospermia,
has revolutionized the field of assisted reproduction. The techniques for the retrieval of spermatozoa vary from
relatively simple percutaneous sperm aspiration to open excision (testicular biopsy) and the more invasive
Micro-TESE. The probability of retrieving spermatozoa can be as high as 100% in men with obstructive
azoospermia (congenital bilateral absence of the vas deferens, status post-vasectomy). However, in non-
obstructive azoospermia, successful sperm retrieval has been reported in 10-100% of cases by various
investigators. The surgical retrieval and cryopreservation of sperm, especially in men with non-obstructive
azoospermia, to some extent ensures the availability of sperm at the time of intracytoplasmic sperm injection.
In addition, this strategy can avoid unnecessary ovarian stimulation in those patients intending to undergo in
vitro fertilization-intracytoplasmic sperm injection with freshly retrieved testicular sperm when an absolute
absence of sperm in the testis is identified. Several different methods for the cryopreservation of testicular and
epididymal sperm are available. The choice of the container or carrier may be an important consideration and
should take into account the number or concentration of the sperm in the final preparation. When the number
of sperm in a testicular biopsy sample is extremely low (e.g., 1-20 total sperm available), the use of an evacuated
zona pellucida to store the cryopreserved sperm has been shown to be an effective approach.
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& INTRODUCTION
The introduction of intracytoplasmic sperm injection
(ICSI), a technique for the fertilization of oocytes, has
revolutionized the field of in vitro fertilization and assisted
reproduction, especially in couples with male factor
infertility. The report (1) of successful live births following
the fertilization of metaphase II oocytes by the injection of a
single sperm in couples for whom in vitro fertilization (IVF)
and subzonal injection (SUZI) of sperm had previously
failed represented a major milestone. Initially, these
investigators used freshly ejaculated spermatozoa for ICSI,
but soon thereafter, pregnancy and live births were reported
using sperm retrieved from the testes (2) and epididymis
(3). The technique of testicular sperm extraction was first
introduced in 1993 (2,4) to retrieve sperm from patients with
obstructive azoospermia (OA). Pregnancies resulting from
the testicular sperm of obstructive azoospermic patients
were followed by reports of successful outcomes using the
testicular sperm from patients with non-obstructive azoos-
permia (NOA) (5-11). Nowadays, ICSI using frozen testi-
cular (12) and epididymal (13) sperm has become an
effective and standard approach to treating infertility
secondary to obstructive and non-obstructive azoospermia.
The cryopreservation of mammalian sperm has been
practiced for decades. In fact, ejaculated spermatozoa were
the first successfully cryopreserved human cells (14). The
use of cryopreserved ejaculated sperm in intrauterine
insemination and IVF is a standard practice. The Food and
Drug Administration enforces a quarantine period before
sperm from anonymous donors can be used, thus requiring
the cryopreservation and storage of donor sperm for at least
six months. Generally, the large number of sperm (usually
in the millions) in semen makes the cryopreservation of
ejaculated sperm easy and feasible, as even after a loss in
viability following the thawing of sperm, enough live and
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motile sperm are available for insemination or IVF. In
comparison, the cryopreservation of surgically retrieved
testicular sperm is more cumbersome and difficult because
of the low number (total count) of sperm retrieved and their
lack of motility. In addition, the testicular sperm prepara-
tions are almost always contaminated with a high propor-
tion of cellular debris and blood cells. The basic principles
and methods of sperm cryopreservation for testicular,
epididymal, and ejaculated sperm are, however, similar
and involve the use of glycerol as a cryoprotectant. The
cryopreservation of testicular and epididymal sperm has
now become a standard technique in the management of
male factor infertility.
& REASONS FOR AND ADVANTAGES OF THE
CRYOPRESERVATION OF TESTICULAR AND
EPIDIDYMAL SPERM
The complete absence of sperm in the ejaculate following
two-three days of abstinence on at least two occasions is the
standard used to confirm the diagnosis of azoospermia. This
diagnosis is the primary reason for attempting sperm
retrieval from the testis for use in IVF-ICSI. Azoospermia
can be caused by epididymal pathology or an obstruction in
the reproductive tract at the post-testicular/epididymal
locus in men who have otherwise normal spermatogenesis.
Obstructive azoospermia (OA) also occurs in men with
vasectomy or pathological blockage of the vas deferens.
Mutations in the cystic fibrosis trans-membrane conduc-
tance regulator (CFTR) gene are a relatively frequent cause
of the congenital bilateral absence of the vas deferens
(CBAVD) leading to azoospermia.
In men with OA, the probability of acquiring sperm from
testes is almost guaranteed, and the surgical retrieval of
sperm can be scheduled at the convenience of the patient,
urologist, and laboratory personnel. Thus, sperm can be
cryopreserved in advance of the oocyte retrieval from the
female partner. This flexibility not only avoids having to
plan the testicular biopsy surgery to coincide with the egg
retrieval but also avoids both partners having to undergo
surgical procedures at approximately the same time. On
rare occasions, men with an infertility diagnosis of ductal
obstruction may present with a failure of spermatogenesis,
and a fresh biopsy on the day of oocyte retrieval with no
available sperm may cause undue psychological stress and a
financial burden for the couple.
The cryopreservation of spermatozoa in multiple vials/
aliquots confers the advantage of enabling multiple IVF-
ICSI attempts without the male partner undergoing surgery
for each attempt. Multiple testicular biopsies or the removal
of an excessive amount of tissue can cause irreversible
damage and in some cases may result in testicular atrophy
(15). Patients who have had a vasectomy for personal
reasons but wish to undergo vas reconstruction surgery to
regain fertility are also candidates for the cryopreservation
of testicular sperm. Testicular sperm can be retrieved and
cryopreserved at the time of vas re-anastomosis. This
strategy ensures the availability of sperm if the reconstruc-
tion fails (probability of 20-25%) (16) and avoids a repeat
surgical sperm retrieval. Patients undergoing exploratory
surgery to assess the cause of azoospermia should also be
counseled to freeze testicular sperm at this time if possible,
thus avoiding another surgical intervention.
With the advances in the field of cancer treatment, the
survival rate for a variety of malignant diseases in recent
years has significantly improved. A significant proportion of
boys diagnosed with some form of childhood (pre-pubertal)
cancer are cured and able to maintain a normal adult life. In
male children (10-13 years of age) diagnosed with some form
of malignancy, spermatogenesis may not be fully established,
and ejaculated spermatozoa may not be available for bank-
ing. However, in such patients, isolated portions of the
seminiferous tubules may contain enough sperm for cryo-
preservation and ICSI. Even in younger males in whom
spermatogenesis has not yet been initiated, the cryopreserva-
tion of testicular tissue before starting chemo- or radio-
therapy offers fertility potential in the future (17).
In men with non-obstructive azoospermia (NOA), obtain-
ing enough sperm for cryopreservation may pose a challenge.
Depending on the etiology and severity of the underlying
condition, none to a fair number of testicular sperm can be
retrieved. In 10-15% of patients diagnosed with NOA, the
condition is attributed to micro-deletions in the long arm of
the Y chromosome (AZF region). The micro-deletion of two
genes, USP9Y and DDX3Y, in the AZFa region invariably
results in the appearance of Sertoli cell-only syndrome and
the complete absence of spermatogenesis in the seminiferous
tubules. Depending on the extent and size of the deletions in
the AZFb region, complete absence of spermatogenesis or
focal hypo-spermatogenesis in isolated seminiferous tubules
can occur. Deletions in the distal AZFc region produce a wide
array of aberrations in spermatogenesis, often resulting in
mild to severe hypo-spermatogenesis and leading to severe
oligospermia or even ejaculatory azoospermia. Other causes
of NOA may be attributed to cryptorchidism, spermatic cord
torsion, testicular or inguinal surgery/infection/trauma,
history of radiation and chemical exposure, endocrine
disruption, or, in some cases, the use of medications
associated with the impairment of sperm production. The
probability of recovering sperm obviously depends on the
extent and severity of each case.
In patients with NOA, it is difficult to predict a successful
retrieval of testicular sperm, as no definitive markers of
spermatogenesis have been described. Testicular measure-
ments (e.g., size, volume, and plasma FSH concentrations)
do not accurately predict the success of testicular biopsy in
obtaining enough sperm for ICSI. The treatment of the
female partner of NOA patients with gonadotropins in
anticipation of oocyte retrieval and ICSI may be unnecessary
in up to 50% of patients, as it is possible that no sperm may
be available following the testicular biopsy. An exploratory
testicular biopsy surgery with ‘‘possible testicular sperm
freeze’’ is a valid option and should be offered to the couple.
If there is evidence of rare sporadic hypo-spermatogenesis
in the seminiferous tubules, the few spermatozoa that are
retrieved may be frozen at this time. If it is doubtful whether
enough spermatozoa will be available for ICSI post-thaw,
the couple may be advised to undergo a fresh biopsy on the
day before or on the morning of oocyte retrieval. Patients
with NOA often have decreased testicular volumes, and
multiple biopsies with the excision of excessive testicular
parenchyma carry the risk of irreversible damage and
atrophy. Couples hesitant to undergo a repeat biopsy may
be offered donor sperm as a back-up in case the number of
mature oocytes exceeds the number of available viable
testicular sperm for ICSI. This strategy offers the patient and
the healthcare provider the advantage of knowing if there
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are sperm available and if alternate arrangements may be
needed. Because the number of sperm retrieved for
cryopreservation in NOA patients may be extremely low,
the loss of a few sperm during the freeze/thaw cycle can be
significant and is a very real disadvantage.
& SURGICAL TECHNIQUES FOR SPERM RETRIEVAL
In patients with documented OA, sperm can be surgically
retrieved from the testis or epididymis. In comparison, men
with NOA are restricted to testicular surgery for the retrieval
of male gametes. A variety of surgical approaches, ranging
from percutaneous aspiration to open biopsy, have been
successfully employed for sperm retrieval. Although enough
sperm for IVF-ICSI in a fresh cycle may be retrieved by a
particular surgical technique (such as needle aspiration), if
the intent is to cryopreserve multiple aliquots for future use,
techniques that yield higher numbers of sperm, such as open
biopsy and micro-TESE, may be more suitable options.
Retrieval of testicular sperm
Open testicular biopsy. This conventional method of
surgical sperm extraction generally offers the best chance of
retrieving spermatozoa, irrespective of the etiology of
azoospermia. Open biopsy also allows the excision of a
larger tissue mass, allowing access to a greater number of
sperm available for freezing. The major drawback of open
biopsy, from the point of view of the patient, is the size of the
wound and the healing time compared with other forms of
aspiration, namely needle aspiration. In men with NOA,
open testicular biopsy is more effective than testicular sperm
aspiration (TESA) or multiple fine needle aspirations (FNAs).
Patients with focal spermatogenesis or hypospermatogenesis
are also best served with open biopsy or, in some cases, with
micro-TESE (or micro-dissection TESE). Micro-TESE is a
more invasive surgical procedure involving a thorough
examination under an operating microscope of the
bifurcated gonad to locate and excise the seminiferous
tubules exhibiting active spermatogenesis. The sperm
retrieval rate by micro-TESE has been reported as superior
to that of conventional TESE (18-20), especially in patients
with focal and sporadic spermatogenesis. The excision of
isolated seminiferous tubules with active spermatogenesis in
micro-dissection TESE results in the removal of significantly
less tissue (average of 9.4 mg) compared with a standard
biopsy (720 mg) (18). The advantages of micro-TESE in
addition to the superior sperm retrieval rate include the
avoidance of complications such as hematoma, fibrosis, and
impaired androgen production (18).
Testicular sperm aspiration (TESA). Testicular sperm
aspiration or percutaneous testicular sperm aspiration is a
technique originally described as a diagnostic procedure
used to evaluate spermatogenesis in azoospermic patients
(21). In this technique, a 19- or 21-gauge needle attached to a
20-ml syringe is used to percutaneously puncture the testis,
and negative pressure is applied to aspirate the tubules.
Fragments of the seminiferous tubules are analyzed for the
presence of sperm. Since the development of ICSI, in which
a single viable sperm per mature oocyte is needed for
fertilization, the availability of a few spermatozoa has been
enough to offer a chance of pregnancy. In men with OA,
testicular sperm aspiration invariably generates enough
sperm for IVF-ICSI. In general, the number of sperm
obtained by open biopsy (TESE) is significantly higher
than that obtained by needle aspiration. A variation of
TESA, testicular fine needle aspiration (TEFNA, FNA),
involves the aspiration of tubules from multiple sites in
the gonad. Multiple testicular fine needle aspirations have
been attempted in men with NOA with varying success. In
men with NOA, the success of sperm retrieval by FNA
depends on the etiology and severity of the underlying
cause of the azoospermia. In a prospective study comparing
the efficacy of multiple needle biopsies with open testicular
excision, spermatozoa were retrieved in only 14% of the
patients with non-obstructive azoospermia by multiple
needle aspirations and in 63% of patients following open
excision biopsy (22). The probability of retrieving testicular
sperm in NOA by various surgical techniques is presented
schematically in Figure 1.
Retrieval of epididymal sperm
Percutaneous epididymal sperm aspiration (PESA). PESA
involves the insertion of a 23-gauge butterfly needle through
the scrotal skin into the epididymis. Negative suction
pressure is applied using a 10-ml syringe containing a
small volume of culture medium. The epididymal fluid
mixed with culture medium is then examined for the
presence of motile sperm. The procedure may involve
multiple punctures at different locations in the epididymis
until live sperm are found. PESA may be a good option for
patients with ductal obstruction distal to the epididymis.
Microsurgical epididymal sperm aspiration (MESA). The
technique of MESA involves the surgical exposure of the
epididymis and the aspiration of the effluent from the
epididymal tubules under optical magnification. It is the
technique of choice for some surgeons to surgically retrieve
sperm because of the high concentration and quality of
spermatozoa obtained compared with that of testicular
sperm, especially in patients with irreparable epididymal
obstruction. Epididymal spermatozoa are mature and
progressively motile, and epididymal aspirates are much
cleaner and devoid of the cellular debris that is seen in
testicular sperm preparations. The motility of epididymal
sperm makes sperm selection during ICSI easier without the
introduction of additional steps (such as treatment with
Figure 1 - Probability of retrieving sperm in NOA by various
surgical procedures (high to low).
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motility-enhancing agents) that may be needed to identify
viable gametes if testicular sperm are used. In a study
comparing the two techniques of sperm retrieval from the
epididymis (PESA and MESA), sperm were successfully
retrieved by PESA in 61% of patients with obstructive
azoospermia, compared with a 93% sperm retrieval rate by
MESA (23).
& CRYOPRESERVATION OF TESTICULAR SPERM
I. Materials and Equipment
Sterile culture dishes
Polystyrene conical tubes
Sterile glass pipettes
Syringes (50 ml)
Syringes (3 ml) with 21-gauge needles
Syringe filter (Nalgene, 0.22 mm)
Microscope glass slides
Coverslips
Gloves
Sterile pair of curved iris scissors
Sterile pair of forceps
Bench-top clinical centrifuge
Microscope
Refrigerator
Weighing chemical balance
Cryo vials
Aluminum canes
Plastic cryosleeves
Liquid nitrogen dewar
Liquid nitrogen
Personal protective gear for handling liquid nitrogen
II. Reagents
Quinn’s Sperm Washing Medium (modified human tubal
fluid with human serum albumin, 5 mg/ml; SAGE IVF Inc.,
Trumbull, CT, USA).
Sperm Freezing Medium (20% TEST Yolk buffer, 12%
glycerol with gentamycin sulfate; Irvine Scientific, Santa
Ana, CA, USA).
Tissue culture-grade water (SAGE IVF Inc., Trumbull, CT,
USA).
RBC Lysis Buffer (155 mM ammonium chloride, 10 mM
potassium bicarbonate, 2 mM EDTA; pH 7.2).
Preparation of RBC lysis buffer
Ammonium chloride (NH4Cl) 0.829 g
Potassium bicarbonate (NaHCO3) 0.100 g
Ethylenediaminetetraacetic acid (EDTA) 0.074 g
Tissue culture-grade water 100 ml
Dissolve and adjust the pH to 7.2. Sterilize the buffer
using a 0.2-mm syringe filter and store in the refrigerator at
4 C˚ for up to four weeks.
Procedure
(The procedure can be performed at room temperature)
1. Rinse the tissue in sperm-washing medium to remove
the blood and transfer it to a sterile petri dish.
2. Using a pair of sterile curved iris scissors, mince the tissue
well. Keep the tissue moist with the sperm-washing
medium during mincing. Add 1.0 ml of the sperm-
washing medium to the finely minced tissue. Tilt the
dish, aspirate the medium, and transfer the suspension to
a conical tube (A) while leaving the larger tissue fragments
in the dish.
3. Add 2.0 ml of the sperm-washing medium to the petri
dish. Using a 3-cc syringe attached to a 21-gauge needle,
gently aspirate the tissue suspension repeatedly. The
repeated aspiration through the syringe needle dissoci-
ates the seminiferous tubules and releases the sperm
from the tubular lumen.
4. Transfer the suspension to the same conical tube (A) used
in step 2 and let it stand at room temperature for 5-10
minutes. The large tissue fragments tend to settle at the
bottom. Transfer the supernatant to a new conical tube (B).
5. Add 1-2 ml of the sperm-washing medium to the tissue
pellet and mix well with a Pasteur pipet.
6. Allow the tissue fragments to settle for 5 minutes and
transfer the supernatant to the conical tube (B).
7. Centrifuge the conical tube (B) at 400 g for 10 minutes.
8. Gently aspirate and discard the supernatant, leaving the
pellet at the bottom.
9. Add 3-4 ml of RBC Lysis Buffer to the pellet and mix
with a Pasteur pipet.
10. Centrifuge at 400 g for 5 minutes.
11. Gently aspirate the supernatant and discard it without
disturbing the pellet.
12. Re-suspend the pellet in 3.0 ml of the sperm-washing
medium and centrifuge the conical tube at 400 g for 10
minutes to wash off the RBC Lysis Buffer.
13. Discard the supernatant and resuspend the pellet in
0.5-1.0 ml of the sperm-washing medium.
14. Add an equal volume of TEST-Yolk sperm cryopre-
servation medium to the sperm suspension and
aliquot the mixture into 3-4 labeled cryovials.
15. Cool the cryovials to 4 C˚ (in the refrigerator) for 30-45
minutes.
16. Expose the vials to the liquid nitrogen vapor phase (8-
10 inches above the liquid nitrogen level) for an hour.
17. Plunge the frozen vials into liquid nitrogen for storage.
& CRYOPRESERVATION OF EPIDIDYMAL SPERM
1. Once the presence of sperm is documented by micro-
scopic examination of the epididymal aspirate, the fluid
is transferred to a conical tube.
2. Add 1-2 ml of the sperm-washing medium to the conical
tube containing the epididymal fluid. Mix gently.
3. Centrifuge the conical tube at 400 g for 10 minutes.
4. Discard the supernatant. If the pellet appears to be
contaminated with erythrocytes, blood cells may be
removed by washing the pellet with RBC Lysis Buffer
as follows.
5. Re-suspend the pellet in 2 ml of RBC Lysis Buffer. Mix
gently.
6. Centrifuge the conical tube at 400 g for 5 minutes.
7. Gently aspirate the supernatant and discard without
disturbing the sperm pellet.
8. Wash the pellet with 1-2 ml of the sperm-washing
medium by centrifuging the tube at 400 g for 10 minutes.
9. Re-suspend the pellet in 1.0 ml of the sperm-washing
medium.
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10. Add an equal volume (1.0 ml) of TEST-Yolk sperm
cryopreservation medium to the epididymal sperm
suspension.
11. Aliquot the mixture into 3-4 labeled cryovials for cryo-
storage.
12. Place the cryovials in a 4 C˚ refrigerator for 30-45
minutes and then freeze the cryovials in liquid
nitrogen vapor for 1 hour.
13. Plunge the vapor-frozen vials into liquid nitrogen for
storage.
& PROCEDURE FOR THAWING THE TESTICULAR
AND EPIDIDYMAL SPERM
Note: Use proper safety precautions and personal
protective gear while handling liquid nitrogen.
1. Before thawing, locate, identify, and confirm the patient
information on the vial.
2. Take the vial out of the liquid nitrogen and thaw at room
temperature for 10 minutes.
3. Transfer the contents of the vial into a conical tube. Add
1-2 ml of the sperm-washing medium slowly, drop by
drop, to the thawed suspension. Mix the contents gently.
4. Centrifuge the tube at 400 g for 10 minutes.
5. Gently aspirate the supernatant and discard it without
disturbing the sperm pellet.
6. Re-suspend the pellet in 1-2 ml of the sperm-washing
medium and centrifuge the tube again at 400 g for 10
minutes.
7. Gently remove the supernatant. Re-suspend the sperm
pellet in 50-100 ml of the sperm-washing medium.
8. The sperm suspension is ready for ICSI.
& METHODS FOR THE CRYOPRESERVATION OF
SINGLE (OR FEW) SPERM
The procedure for the cryopreservation of testicular and
epididymal sperm as described in detail in the preceding
section is a standard technique when several hundred to
thousands or a million sperm are available for preservation.
For some patients with NOA, the retrieval of only a few (less
than 100, and sometimes as few as 10 or less) sperm poses a
technical challenge for cryopreservation and, later, at the
time of warming for the successful retrieval of these few
gametes for ICSI. Several investigators have attempted to
cryopreserve extremely low number of sperm (and some-
times a single sperm) in small volumes using various
carriers (Table 1). The two methods that have resulted in
successful pregnancies and live births involve the use of
empty zona (human, mouse, or hamster) and cryoloops.
These methods are briefly summarized below.
Cryopreservation of a single human sperm using a
zona pellucida
Cohen and colleagues (24) were the first to report this
unique method of the cryopreservation of a single sperma-
tozoon inside empty zona obtained from mouse, hamster, or
human oocytes. The oocytes were treated with hyaluroni-
dase to remove the cumulus and corona cells. The denuded
oocyte was held by a holding pipette, and two small holes
were drilled into the zona (by mechanical breach, acid
tyrodes solutions, or a laser). The ooplasm was aspirated by
suction, leaving the zona empty of its contents. The
testicular suspension was carefully examined under the
microscope for the presence of spermatozoa, and once a
twitching/moving sperm was found, it was transferred to a
PVP (10%) droplet. This procedure was repeated until a few
sperm had been retrieved. The next step involved the
insertion of one or more (up to 15) sperm into empty zona
using an ICSI needle. Injected zonae containing sperm were
placed into an 8% glycerol solution in phosphate-buffered
saline (PBS) containing human serum albumin (3%). The
zonae were then frozen individually in sterile straws
(0.25 ml). Each zona was placed in a column of cryopre-
servation medium sandwiched between two air bubbles.
The straws were heat-sealed and exposed to liquid nitrogen
vapor for two hours, followed by storage in liquid nitrogen.
The spermatozoa were recovered by thawing the straw in
a water bath (30 C˚) for 30 seconds. One end of the straw was
cut with a pair of sterile scissors, and the content of the
Table 1 - Carriers used for sperm cryopreservation in microquantities.
Carrier Advantages Disadvantages Comments References
Empty zona (mouse,
hamster, or human)
Easy to handle the zona
envelope; good sperm
recovery and survival
Human or non-human biological material; Labor-
intensive; Requires micromanipulation and in-
house evacuation and preparation of the zona
envelope
Successful pregnancy 24,25,45,46
Cryoloop Commercially available Requires a micromanipulator to load sperm onto
the loop and is somewhat labor-intensive
Successful pregnancy 27,28,47
Mini straws or open-
pulled straws
Easy and simple technique Not feasible for an extremely low volume/
number of sperm
Can be used to freeze severely
oligospermic samples
48
ICSI pipette Commercially available;
found in every IVF lab
Fragile glass pipette; difficult to store and
handle in liquid nitrogen
No reported pregnancies 49
Microdroplets Easy and relatively simple
technique
Difficult to handle and store in liquid nitrogen;
Culture dishes are fragile when stored in
liquid nitrogen; Variable recovery rates
Has yielded successful
pregnancies; has not received
widespread acceptance
50-52
Volvox globator algae Inexpensive; plentifully
available
Non-human biological material; labor-
intensive advance preparation of algae spheres
Not suitable for human clinical
use
53
Alginate beads or
agarose microspheres
Inert polymers used as
carriers
Very labor-intensive technique No report of clinical
pregnancies
54,55
Cryotop Commercially available,
easy to load and handle
- Sperm recovery, survival
similar to that obtained using
the empty zona method
56
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straw was expelled into a sterile dish. The zona was
recovered and washed several times in HEPES-buffered
medium. The zona containing the sperm was then trans-
ferred to a droplet of PVP (12%). Using a holding pipette,
the zona envelope was positioned to permit the penetration
of the ICSI needle through the slit (used earlier to evacuate
the ooplasm). The ICSI needle was inserted into the zona,
and the sperm was aspirated gently and released into the
PVP droplet. The sperm was immobilized and injected into
the metaphase II oocyte, held in a drop of HEPES-buffered
medium. This technique of the cryopreservation of indivi-
dual spermatozoa inside an empty zona, although quite
labor-intensive and time-consuming, offers an opportunity
to retrieve and store sperm in extreme cases of male factor
infertility. Successful pregnancies and live births have been
reported with this method (25).
Cryopreservation of sperm using the cryoloop
method
The use of a cryoloop as a carrier to contain the frozen
embryos was initially proposed by Lane and colleagues (26).
The premise of holding the embryo on a thin film of
cryoprotectant solution on a small (0.5-0.7 mm) loop has the
advantage of enabling the handling of a very small volume
(2 ml) with excellent recovery rates. The use of cryoloops
was thereafter extended to freeze a very small number of
sperm (27). The method of cryopreservation on cryoloops
was refined to enable the freezing of individual sperm by
loading the sperm onto the cryoloop by a micromanipula-
tion technique (28). The procedure of single sperm
cryopreservation involves holding the cryoloop on a
magnetic wand. The magnetic wand is attached to the
micromanipulator on an inverted microscope and is
lowered to visualize the loop. The spermatozoa are isolated
using a micropipette (e.g., ICSI pipet) and concentrated onto
a microdrop of HEPES-buffered medium, supplemented
with 1% human serum albumin. Just before loading the
sperm onto the cryoloop, the individual sperm is transferred
to another microdrop of a 1:1 mixture of HEPES medium
and sperm cryopreservation medium (TEST-Yolk buffer
containing 12% glycerol; Irvine scientific, Santa Ana, CA).
Using a micropipette, sperm are then loaded onto the film in
the loop. The cryoloop attached to the cap is screwed onto
the cryovial, and the vial is exposed to liquid nitrogen vapor
for up to 30 minutes before being plunged into liquid
nitrogen for storage.
Sperm frozen on the cryoloop are thawed at room
temperature using a dissecting binocular microscope. The
cryoloop attached to the cap is unscrewed under liquid
nitrogen and is swiftly shifted under the binoculars over a
sterile culture dish. The loop is held so that it touches the
surface of the dish, and it is cut with a scalpel from the metal
shaft. Immediately, 2 ml of HEPES-buffered medium sup-
plemented with albumin is laid on top of the loop, and the
droplet is overlaid with mineral oil. Spermatozoa may be
individually moved to a fresh drop of medium, washed,
and then transferred to PVP before ICSI.
The cryoloop method for the cryopreservation of a single
spermatozoon is also labor-intensive and time-consuming
and requires extensive training and experience. The
cryopreservation of a single sperm, although it is feasible
and has had documented success, is rarely practiced, and
alternative options, such as fresh biopsy with donor sperm
back-up, are more prevalent.
& OUTCOME
Obstructive azoospermia
The use of testicular and epididymal sperm in the
treatment of male factor infertility secondary to OA has
now become a standard approach. The probability of
retrieving sperm in men with OA is close to 100%. In men
with OA, the use of fresh testicular sperm for ICSI
invariably offers fertilization, pregnancy, and live birth
rates that are comparable to those derived from the use of
ejaculated sperm in age-matched controls. The use of frozen
testicular sperm from OA patients for ICSI offers fertiliza-
tion, implantation, and clinical pregnancy rates that are
equivalent to those derived from the use of freshly retrieved
testicular sperm (Table 2). Fertilization and clinical preg-
nancy rates are also similar between spermatozoa of
epididymal or testicular origin (29). MESA is the preferred
method of sperm recovery if the obstruction is determined
to be at a location distal to the epididymis. The use of either
fresh or frozen epididymal sperm offers comparable
fertilization, embryonic development, implantation, and
clinical pregnancy rates (30). Fertilization and pregnancy
rates across different sperm retrieval methods and obstruc-
tion etiologies are also comparable (23). The number of
Table 2 - Outcomes using testicular sperm in patients with obstructive azoospermia.
Testicular Sperm Fertilization (%)
Embryonic
Cleavage (%) Implantation (%)
Clinical
Pregnancies (%)
Ongoing/Live
births (%) References
Fresh 52 99 - 0 0 12
Frozen-thawed 51 96 - 6 6
Fresh 58 98 33 33 - 57
Frozen-thawed 64 95 14 32 -
Fresh 64 99 - 30 20 58
Fresh 62 93 - 25 20
Fresh - - - - 23 59
Frozen-thawed - - - - -
Fresh 50 - 18 26 22 60
Frozen-thawed 49 - 14 29 19
Fresh 72 - 33 69 44 31
Frozen-thawed 68 - 17 42 25
Fresh 52 106* 14 24 15 29
Frozen-thawed - - - - -
*.100% because embryos that did not show normal signs of fertilization (2 pronuclei) but that did show cleavage are included.
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high-quality embryos obtained using frozen testicular
sperm is similar to that obtained using fresh testicular
sperm (31). Despite the high pregnancy rates achieved using
fresh and frozen surgically retrieved sperm, there is some
concern that the use of testicular sperm results in higher
miscarriage rates compared with the use of ejaculated
sperm (31-33). The rate of aneuploidy in testicular and
epididymal spermatozoa in OA patients is similar to that
observed in sperm from normal men (34), suggesting that
the higher incidence of early miscarriages cannot be
attributed to the paternal genome. Testicular sperm are
generally immature but undergo maturation during their
passage through the epididymis. Immature testicular sperm
are easily recognizable by the presence of large cytoplasmic
droplets attached to their middle pieces and necks. It has
been suggested that reactive oxygen species in cytoplasmic
droplets may cause irreversible DNA damage (35) in
immature testicular sperm, resulting in a higher miscarriage
rate (31).
Non-obstructive azoospermia
The probability of sperm retrieval in NOA is dependent
on two factors, namely the etiology of NOA and the surgical
approach. In general, microdissection TESE or open biopsy
is more successful than needle aspiration. In approximately
13% of men diagnosed with NOA, the failure of spermato-
genesis may be attributed to Y chromosome microdeletions.
The probability of retrieving spermatozoa in men who have
microdeletions in the AZFa and/or AZFb regions is close to
zero, whereas men with AZFc microdeletions have an
approximately 70% chance of having enough sperm avail-
able for ICSI (36). Although the reports detailing the rates of
testicular sperm retrieval in men with NOA range from 14-
87% (Table 3), a conservative estimate of an overall 50-60%
chance of successful sperm retrieval is appropriate. In
general, the total number of sperm retrieved in NOA is
significantly less than that obtained in OA. The cryopre-
servation of sperm in general results in a decrease in post-
thaw motility and vitality. This loss of viability can be of
great concern in NOA because of the low number of sperm
available; however, unique approaches to the freezing of
single/individual sperm now offer excellent post-thaw
recoveries.
It is well documented that spermatozoa in men with
oligoasthenoteratozoospermia exhibit an increased inci-
dence of chromosomal abnormalities (37-40). Interestingly,
a comparison of aneuploidy frequency between embryos
derived from testicular sperm from men with OA and from
Table 3 - Rate of testicular sperm retrieval in men with non-obstructive azoospermia.
Sperm Retrieval Technique Rate of Sperm Retrieval Comment References
TESE 13/15 (87%) 5
Micro-TESE 17/27 (63%) 9
TESE 15/25 (60%)
TESE 14/18 (78%) 61
TESE 22/35 (63%) Compared TESE and Multiple FNAs 22
Multiple FNAs 5/35 (14%)
TESE 33/55 (60%) 43
TESE 43/64 (67%) 62
TESE 15/42 (36%) 63
TESA 22/86 (26%) 64
TESE 5/48 (10%) 48 patients with failed TESA
underwent TESE
TESE 10/22 (45%) Compared TESE and Micro-TESE 18
TESE 10/17 (59%) 65
TESE 18/31 (58%) 66
Multiple TESE 13/37 (35%) Compared multiple TESE and Micro
TESE
67
Micro-TESE 24/56 (43%) 67
FNA 35/51 (69%) 2 patients who had no sperm
retrieved during the first FNA attempt
had a positive sperm retrieval during
the second FNA attempt
68
TESE 5/12 (42%) Post-chemotherapy azoospermia 69
TESE 23/30 (77%) 31
TESE 261/628 (42%) First attempt 70
If no sperm retrieved, patients had
multiple repeat biopsies
77/103 (74%) Second attempt
28/34 (82%) Third attempt
11/11 (100%) Fourth attempt
5/6 (83%) Fifth Attempt
2/2 (100%) Sixth attempt
384/784 (49%) Overall
Micro-TESE 57% Compared TESE and Micro-TESE 71
TESE 32%
TESE/Micro-TESE 65/138 (47%) 72
TESE 87/258 (34%) Compared TESE and Micro-TESE 73
Micro-TESE 16/77 (21%)
TESE+Micro-TESE 131/258 (51%)
Micro-TESE 37/65 (57%) Compared TESE and Micro-TESE 20
TESE 26/68 (38%) 20
Micro-TESE 27/73 (37%) Post-chemotherapy azoospermia 74
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those with NOA revealed no difference between the two
groups (41), suggesting the chromosomal normalcy of the
testicular sperm. However, a study comparing surgically
retrieved versus ejaculated sperm showed a significantly
higher incidence of chromosomal abnormalities in surgi-
cally retrieved sperm from men with OA and NOA
compared with normospermic ejaculated sperm (42).
Despite differences in the study designs that make any
comparison of outcome results between OA and NOA
difficult, it appears that if sperm are retrieved and viable
gametes are available for ICSI, the fertilization, implanta-
tion, and pregnancy rates resulting from the use of fresh
sperm from men with NOA (Table 4) are in line with those
resulting from the use of sperm from men with OA (Table 3).
Therefore, the cryopreservation of sperm does not affect the
fertilization and pregnancy outcomes.
& CONCLUSION
Successful pregnancies resulting from the use of surgi-
cally retrieved spermatozoa for ICSI (2) were first reported
in 1993. Various surgical techniques, ranging from less
invasive percutaneous aspiration to highly invasive open
testicular biopsy and micro-dissection TESE, are employed.
In OA, the probability of obtaining sperm from the testis is
almost guaranteed. In men with non-obstructive azoosper-
mia, freshly retrieved sperm offers the best chance of
pregnancy; however, in 30-50% of NOA patients, it is still
possible that no sperm may be retrieved (43). In patients
with frozen sperm, sometimes no viable sperm may be
available at the time of ICSI. The incidence of complete non-
viability or the inability to find any injectable sperm post-
thaw in NOA patients is reported to be approximately 20%
(44). The availability of viable sperm, regardless of the
source (testis or epididymis), at the time of ICSI largely
dictates the outcome of fertilization. Frozen (testicular or
epididymal) sperm are as effective as freshly retrieved
sperm. In NOA patients with severe hypospermatogenesis
or focal spermatogenesis, where very few sperm are
retrieved and the cryopreservation of individual (few)
sperm using specialized methods (such as the empty zona
or cryoloop method) is not feasible, a fresh biopsy should be
offered. The injection of sperm using non-motile spermato-
zoa results in a significantly lower fertilization and live birth
rate, emphasizing the importance of the motility/viability of
sperm (43). Currently, there are no definitive parameters,
besides surgical testicular exploration, that are reliable in
predicting the presence of sperm in men with NOA.
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